Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb StudyRegina Dittmann, David Coghill, Esther Cardo et al.|CNS Drugs|2013Cited by 88
A Post Hoc Comparison of the Effects of Lisdexamfetamine Dimesylate and Osmotic-Release Oral System Methylphenidate on Symptoms of Attention-Deficit Hyperactivity Disorder in Children and AdolescentsCésar A. Soutullo, David Coghill, Colleen Anderson et al.|CNS Drugs|2013Cited by 44
958 – Efficacy Of Lisdexamfetamine Dimesylate In Children And Adolescents With Attention-deficit/hyperactivity Disorder: Effect Of Age, Sex And Baseline Disease SeverityMichel Lecendreux, David Coghill, Tobias Banaschewski et al.|European Psychiatry|2013Cited by 2
957 – Post Hoc Comparison Of The Efficacy Of Lisdexamfetamine Dimesylate And Osmotic-release Oral System Methlyphenidate In Children And Adolescents With AdhdDavid Coghill, Liza Squires, Tobias Banaschewski et al.|European Psychiatry|2013Cited by 2
Duration of response of lisdexamfetamine dimesylate in children and adolescents with ADHDAlessandro Zuddas, Liza Squires, Tobias Banaschewski et al.|Neuropsychiatrie de l Enfance et de l Adolescence|2012Cited by 1